Global Solid Tumors Drugs Market Research Report 2016

Publisher Name :
Date: 05-Sep-2016
No. of pages: 114
Inquire Before Buying

Notes:

Production, means the output of Solid Tumors Drugs

Revenue, means the sales value of Solid Tumors Drugs

This report studies Solid Tumors Drugs in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering

- Hoffmann-La Roche

- Novartis

- Celgene

- Johnson & Johnson

- Pfizer

- BMS

- AbbVie

- AbGenomics

- ADC Therapeutics

- TG Therapeutics

- Polaris Pharmaceuticals

- Immunogen

- CTI BioPharma

- Chugai Pharmaceutical

- NewLink Genetics

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Solid Tumors Drugs in these regions, from 2011 to 2021 (forecast), like

- North America

- Europe

- China

- Japan

- Southeast Asia

- India

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into

- Type I

- Type II

- Type III

Split by application, this report focuses on consumption, market share and growth rate of Solid Tumors Drugs in each application, can be divided into

- Application 1

- Application 2

- Application 3

Global Solid Tumors Drugs Market Research Report 2016

Table of Contents
Global Solid Tumors Drugs Market Research Report 2016
1 Solid Tumors Drugs Market Overview
1.1 Product Overview and Scope of Solid Tumors Drugs
1.2 Solid Tumors Drugs Segment by Type
1.2.1 Global Production Market Share of Solid Tumors Drugs by Type in 2015
1.2.2 Type I
1.2.3 Type II
1.2.4 Type III
1.3 Solid Tumors Drugs Segment by Application
1.3.1 Solid Tumors Drugs Consumption Market Share by Application in 2015
1.3.2 Application 1
1.3.3 Application 2
1.3.4 Application 3
1.4 Solid Tumors Drugs Market by Region
1.4.1 North America Status and Prospect (2011-2021)
1.4.2 Europe Status and Prospect (2011-2021)
1.4.3 China Status and Prospect (2011-2021)
1.4.4 Japan Status and Prospect (2011-2021)
1.4.5 Southeast Asia Status and Prospect (2011-2021)
1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Solid Tumors Drugs (2011-2021)
2 Global Solid Tumors Drugs Market Competition by Manufacturers
2.1 Global Solid Tumors Drugs Production and Share by Manufacturers (2015 and 2016)
2.2 Global Solid Tumors Drugs Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Solid Tumors Drugs Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Solid Tumors Drugs Manufacturing Base Distribution, Sales Area and Product Type
2.5 Solid Tumors Drugs Market Competitive Situation and Trends
2.5.1 Solid Tumors Drugs Market Concentration Rate
2.5.2 Solid Tumors Drugs Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Solid Tumors Drugs Production, Revenue (Value) by Region (2011-2016)
3.1 Global Solid Tumors Drugs Production and Market Share by Region (2011-2016)
3.2 Global Solid Tumors Drugs Revenue (Value) and Market Share by Region (2011-2016)
3.3 Global Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2011-2016)
3.4 North America Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2011-2016)
3.5 Europe Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2011-2016)
3.6 China Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2011-2016)
3.7 Japan Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2011-2016)
3.8 Southeast Asia Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2011-2016)
3.9 India Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2011-2016)
4 Global Solid Tumors Drugs Supply (Production), Consumption, Export, Import by Regions (2011-2016)
4.1 Global Solid Tumors Drugs Consumption by Regions (2011-2016)
4.2 North America Solid Tumors Drugs Production, Consumption, Export, Import by Regions (2011-2016)
4.3 Europe Solid Tumors Drugs Production, Consumption, Export, Import by Regions (2011-2016)
4.4 China Solid Tumors Drugs Production, Consumption, Export, Import by Regions (2011-2016)
4.5 Japan Solid Tumors Drugs Production, Consumption, Export, Import by Regions (2011-2016)
4.6 Southeast Asia Solid Tumors Drugs Production, Consumption, Export, Import by Regions (2011-2016)
4.7 India Solid Tumors Drugs Production, Consumption, Export, Import by Regions (2011-2016)
5 Global Solid Tumors Drugs Production, Revenue (Value), Price Trend by Type
5.1 Global Solid Tumors Drugs Production and Market Share by Type (2011-2016)
5.2 Global Solid Tumors Drugs Revenue and Market Share by Type (2011-2016)
5.3 Global Solid Tumors Drugs Price by Type (2011-2016)
5.4 Global Solid Tumors Drugs Production Growth by Type (2011-2016)
6 Global Solid Tumors Drugs Market Analysis by Application
6.1 Global Solid Tumors Drugs Consumption and Market Share by Application (2011-2016)
6.2 Global Solid Tumors Drugs Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries
7 Global Solid Tumors Drugs Manufacturers Profiles/Analysis
7.1 Hoffmann-La Roche
7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
7.1.2 Solid Tumors Drugs Product Type, Application and Specification
7.1.2.1 Type I
7.1.2.2 Type II
7.1.3 Hoffmann-La Roche Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
7.1.4 Main Business/Business Overview
7.2 Novartis
7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
7.2.2 Solid Tumors Drugs Product Type, Application and Specification
7.2.2.1 Type I
7.2.2.2 Type II
7.2.3 Novartis Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
7.2.4 Main Business/Business Overview
7.3 Celgene
7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
7.3.2 Solid Tumors Drugs Product Type, Application and Specification
7.3.2.1 Type I
7.3.2.2 Type II
7.3.3 Celgene Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
7.3.4 Main Business/Business Overview
7.4 Johnson & Johnson
7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
7.4.2 Solid Tumors Drugs Product Type, Application and Specification
7.4.2.1 Type I
7.4.2.2 Type II
7.4.3 Johnson & Johnson Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
7.4.4 Main Business/Business Overview
7.5 Pfizer
7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
7.5.2 Solid Tumors Drugs Product Type, Application and Specification
7.5.2.1 Type I
7.5.2.2 Type II
7.5.3 Pfizer Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
7.5.4 Main Business/Business Overview
7.6 BMS
7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
7.6.2 Solid Tumors Drugs Product Type, Application and Specification
7.6.2.1 Type I
7.6.2.2 Type II
7.6.3 BMS Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
7.6.4 Main Business/Business Overview
7.7 AbbVie
7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
7.7.2 Solid Tumors Drugs Product Type, Application and Specification
7.7.2.1 Type I
7.7.2.2 Type II
7.7.3 AbbVie Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
7.7.4 Main Business/Business Overview
7.8 AbGenomics
7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
7.8.2 Solid Tumors Drugs Product Type, Application and Specification
7.8.2.1 Type I
7.8.2.2 Type II
7.8.3 AbGenomics Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
7.8.4 Main Business/Business Overview
7.9 ADC Therapeutics
7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
7.9.2 Solid Tumors Drugs Product Type, Application and Specification
7.9.2.1 Type I
7.9.2.2 Type II
7.9.3 ADC Therapeutics Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
7.9.4 Main Business/Business Overview
7.10 TG Therapeutics
7.10.1 Company Basic Information, Manufacturing Base and Its Competitors
7.10.2 Solid Tumors Drugs Product Type, Application and Specification
7.10.2.1 Type I
7.10.2.2 Type II
7.10.3 TG Therapeutics Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
7.10.4 Main Business/Business Overview
7.11 Polaris Pharmaceuticals
7.12 Immunogen
7.13 CTI BioPharma
7.14 Chugai Pharmaceutical
7.15 NewLink Genetics
8 Solid Tumors Drugs Manufacturing Cost Analysis
8.1 Solid Tumors Drugs Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Solid Tumors Drugs
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Solid Tumors Drugs Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Solid Tumors Drugs Major Manufacturers in 2015
9.4 Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
12 Global Solid Tumors Drugs Market Forecast (2016-2021)
12.1 Global Solid Tumors Drugs Production, Revenue Forecast (2016-2021)
12.2 Global Solid Tumors Drugs Production, Consumption Forecast by Regions (2016-2021)
12.3 Global Solid Tumors Drugs Production Forecast by Type (2016-2021)
12.4 Global Solid Tumors Drugs Consumption Forecast by Application (2016-2021)
12.5 Solid Tumors Drugs Price Forecast (2016-2021)
13 Research Findings and Conclusion
14 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer
List of Tables and Figures
Figure Picture of Solid Tumors Drugs
Figure Global Production Market Share of Solid Tumors Drugs by Type in 2015
Figure Product Picture of Type I
Table Major Manufacturers of Type I
Figure Product Picture of Type II
Table Major Manufacturers of Type II
Figure Product Picture of Type III
Table Major Manufacturers of Type III
Table Solid Tumors Drugs Consumption Market Share by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Application 3 Examples
Figure North America Solid Tumors Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure Europe Solid Tumors Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure China Solid Tumors Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure Japan Solid Tumors Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure Southeast Asia Solid Tumors Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure India Solid Tumors Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure Global Solid Tumors Drugs Revenue (Million UDS) and Growth Rate (2011-2021)
Table Global Solid Tumors Drugs Production of Key Manufacturers (2015 and 2016)
Table Global Solid Tumors Drugs Production Share by Manufacturers (2015 and 2016)
Figure 2015 Solid Tumors Drugs Production Share by Manufacturers
Figure 2016 Solid Tumors Drugs Production Share by Manufacturers
Table Global Solid Tumors Drugs Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Solid Tumors Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Solid Tumors Drugs Revenue Share by Manufacturers
Table 2016 Global Solid Tumors Drugs Revenue Share by Manufacturers
Table Global Market Solid Tumors Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Solid Tumors Drugs Average Price of Key Manufacturers in 2015
Table Manufacturers Solid Tumors Drugs Manufacturing Base Distribution and Sales Area
Table Manufacturers Solid Tumors Drugs Product Type
Figure Solid Tumors Drugs Market Share of Top 3 Manufacturers
Figure Solid Tumors Drugs Market Share of Top 5 Manufacturers
Table Global Solid Tumors Drugs Production by Regions (2011-2016)
Figure Global Solid Tumors Drugs Production and Market Share by Regions (2011-2016)
Figure Global Solid Tumors Drugs Production Market Share by Regions (2011-2016)
Figure 2015 Global Solid Tumors Drugs Production Market Share by Regions
Table Global Solid Tumors Drugs Revenue by Regions (2011-2016)
Table Global Solid Tumors Drugs Revenue Market Share by Regions (2011-2016)
Table 2015 Global Solid Tumors Drugs Revenue Market Share by Regions
Table Global Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table North America Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table Europe Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table China Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table Japan Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table Southeast Asia Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table India Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table Global Solid Tumors Drugs Consumption Market by Regions (2011-2016)
Table Global Solid Tumors Drugs Consumption Market Share by Regions (2011-2016)
Figure Global Solid Tumors Drugs Consumption Market Share by Regions (2011-2016)
Figure 2015 Global Solid Tumors Drugs Consumption Market Share by Regions
Table North America Solid Tumors Drugs Production, Consumption, Import & Export (2011-2016)
Table Europe Solid Tumors Drugs Production, Consumption, Import & Export (2011-2016)
Table China Solid Tumors Drugs Production, Consumption, Import & Export (2011-2016)
Table Japan Solid Tumors Drugs Production, Consumption, Import & Export (2011-2016)
Table Southeast Asia Solid Tumors Drugs Production, Consumption, Import & Export (2011-2016)
Table India Solid Tumors Drugs Production, Consumption, Import & Export (2011-2016)
Table Global Solid Tumors Drugs Production by Type (2011-2016)
Table Global Solid Tumors Drugs Production Share by Type (2011-2016)
Figure Production Market Share of Solid Tumors Drugs by Type (2011-2016)
Figure 2015 Production Market Share of Solid Tumors Drugs by Type
Table Global Solid Tumors Drugs Revenue by Type (2011-2016)
Table Global Solid Tumors Drugs Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Solid Tumors Drugs by Type (2011-2016)
Figure 2015 Revenue Market Share of Solid Tumors Drugs by Type
Table Global Solid Tumors Drugs Price by Type (2011-2016)
Figure Global Solid Tumors Drugs Production Growth by Type (2011-2016)
Table Global Solid Tumors Drugs Consumption by Application (2011-2016)
Table Global Solid Tumors Drugs Consumption Market Share by Application (2011-2016)
Figure Global Solid Tumors Drugs Consumption Market Share by Application in 2015
Table Global Solid Tumors Drugs Consumption Growth Rate by Application (2011-2016)
Figure Global Solid Tumors Drugs Consumption Growth Rate by Application (2011-2016)
Table Hoffmann-La Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Hoffmann-La Roche Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Hoffmann-La Roche Solid Tumors Drugs Market Share (2011-2016)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Novartis Solid Tumors Drugs Market Share (2011-2016)
Table Celgene Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Celgene Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Celgene Solid Tumors Drugs Market Share (2011-2016)
Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson & Johnson Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Johnson & Johnson Solid Tumors Drugs Market Share (2011-2016)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Solid Tumors Drugs Market Share (2011-2016)
Table BMS Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table BMS Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure BMS Solid Tumors Drugs Market Share (2011-2016)
Table AbbVie Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AbbVie Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure AbbVie Solid Tumors Drugs Market Share (2011-2016)
Table AbGenomics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AbGenomics Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure AbGenomics Solid Tumors Drugs Market Share (2011-2016)
Table ADC Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table ADC Therapeutics Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure ADC Therapeutics Solid Tumors Drugs Market Share (2011-2016)
Table TG Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table TG Therapeutics Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure TG Therapeutics Solid Tumors Drugs Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Solid Tumors Drugs
Figure Manufacturing Process Analysis of Solid Tumors Drugs
Figure Solid Tumors Drugs Industrial Chain Analysis
Table Raw Materials Sources of Solid Tumors Drugs Major Manufacturers in 2015
Table Major Buyers of Solid Tumors Drugs
Table Distributors/Traders List
Figure Global Solid Tumors Drugs Production and Growth Rate Forecast (2016-2021)
Figure Global Solid Tumors Drugs Revenue and Growth Rate Forecast (2016-2021)
Table Global Solid Tumors Drugs Production Forecast by Regions (2016-2021)
Table Global Solid Tumors Drugs Consumption Forecast by Regions (2016-2021)
Table Global Solid Tumors Drugs Production Forecast by Type (2016-2021)
Table Global Solid Tumors Drugs Consumption Forecast by Application (2016-2021)
  • Global Pregnenolone Market Research Report 2017
    Published: 19-Oct-2017        Price: US 2900 Onwards        Pages: 108
    In this report, the global Pregnenolone market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Pregnenolone in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China - Japan......
  • 2017-2022 Europe Top Countries Vegetarian Softgel Capsules Market Report
    Published: 17-Oct-2017        Price: US 4660 Onwards        Pages: 121
    "This report will be delivered in 2-3 business days after the order is placed." In 2016, the Europe Vegetarian Softgel Capsules market size was xx million USD and it will reach xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. This report studies Vegetarian Softgel Capsules in Europe market, especially in Germany, UK, France, Italy, Russia, Benelux, Turkey and other countries in Europe, focuses on the top players in each country, cov......
  • 2017-2022 North America Vegetarian Softgel Capsules Market Report
    Published: 17-Oct-2017        Price: US 4660 Onwards        Pages: 121
    "This report will be delivered in 2-3 business days after the order is placed." In 2016, the North America Vegetarian Softgel Capsules market size was xx million USD and it will reach xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. This report studies Vegetarian Softgel Capsules in North America market, especially in United States, Canada and Mexico, focuses on the top players in each country, covering - Catalent - Pr......
  • 2017-2022 United States Vegetarian Softgel Capsules Market Report (Status and Outlook)
    Published: 17-Oct-2017        Price: US 3360 Onwards        Pages: 121
    "This report will be delivered in 2-3 business days after the order is placed." In 2016, the Vegetarian Softgel Capsules market size was xx million USD in United States, and it will be xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. In United States market, the top players include - Catalent - Procaps Laboratorios - EuroCaps - Best Formulations - Aenova - Captek - SIRIO - Bahr......
  • P Selectin (CD62 Antigen Like Family Member P or Granule Membrane Protein 140 or Leukocyte Endothelial Cell Adhesion Molecule 3 or LECAM3 or Platelet Activation Dependent Granule External Membrane Protein or CD62P or SELP) - Pipeline Review, H2 2017
    Published: 17-Oct-2017        Price: US 3500 Onwards        Pages: 45
    P Selectin (CD62 Antigen Like Family Member P or Granule Membrane Protein 140 or Leukocyte Endothelial Cell Adhesion Molecule 3 or LECAM3 or Platelet Activation Dependent Granule External Membrane Protein or CD62P or SELP) - Pipeline Review, H2 2017 Summary P Selectin (CD62 Antigen Like Family Member P or Granule Membrane Protein 140 or Leukocyte Endothelial Cell Adhesion Molecule 3 or LECAM3 or Platelet Activation Dependent Granule External Membrane Protein or CD62......
  • Glycoprotein 41 (gp41) - Pipeline Review, H2 2017
    Published: 17-Oct-2017        Price: US 3500 Onwards        Pages: 63
    Glycoprotein 41 (gp41) - Pipeline Review, H2 2017 Summary Glycoprotein 41 (gp41) - Gp41 or glycoprotein 41 is a transmembrane protein that contains several sites within its ectodomain that are required for infection of host cells. It is a subunit of the envelope protein complex of retroviruses. The interaction of gp41 fusion peptides with the target cell causes a formation of an intermediate structure which bridges and fuses the viral and host membranes together. ......
  • 20s Proteasome - Pipeline Review, H2 2017
    Published: 17-Oct-2017        Price: US 3500 Onwards        Pages: 64
    20s Proteasome - Pipeline Review, H2 2017 Summary According to the recently published report '20s Proteasome - Pipeline Review, H2 2017'; 20s Proteasome pipeline Target constitutes close to 7 molecules. Out of which approximately 6 molecules are developed by companies and remaining by the universities/institutes. 20s Proteasome - 20S proteasome is the catalytic core of the 26S proteasome, the central protease of the ubiquitin pathway of protein degrada......
  • Glutamyl Aminopeptidase (EAP or Aminopeptidase A or Differentiation Antigen gp160 or CD249 or ENPEP or EC 3.4.11.7) - Pipeline Review, H2 2017
    Published: 17-Oct-2017        Price: US 3500 Onwards        Pages: 38
    Glutamyl Aminopeptidase (EAP or Aminopeptidase A or Differentiation Antigen gp160 or CD249 or ENPEP or EC 3.4.11.7) - Pipeline Review, H2 2017 Summary Glutamyl Aminopeptidase (EAP or Aminopeptidase A or Differentiation Antigen gp160 or CD249 or ENPEP or EC 3.4.11.7) pipeline Target constitutes close to 5 molecules. Out of which approximately 5 molecules are developed by Companies. The latest report Glutamyl Aminopeptidase - Pipeline Review, H2 2017, outlays comprehe......
  • Global Pediatric Vaccines Market Research Report 2017
    Published: 17-Oct-2017        Price: US 2900 Onwards        Pages: 114
    In this report, the global Pediatric Vaccines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Pediatric Vaccines in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs